Sign Up Today and Learn More About AliveCor Stock
Invest in or calculate the value of your shares in AliveCor or other pre-IPO companies through EquityZen's platform.
AliveCor Stock (ALVC)
AliveCor is a FDA-cleared mobile heart solution that helps save lives, save money, and brings healthcare into the 21st century.
About AliveCor Stock
Founded
2010
Headquarters
Mountain View, CA, US
Industries
Software, Health Care, Mobile
AliveCor has a device and application that will turn any smartphone into a clinical-quality electrocardiogram (ECG) recorder. AliveCor is pioneering the creation of FDA-cleared 'machine learning' techniques to enable proactive heart care and is recognized around the world for transforming cardiac care. It specializes in the fields of healthcare, mobile device, and medicine. It was founded in 2010 and headquartered in Mountain View, California.
AliveCor Press Mentions
Stay in the know about the latest news on AliveCor
Digital Biomarkers Market CAGR of 34.1% size, share and major trends 2024-2031 | AliveCor Inc., Altoida Inc., Amgen Inc.
einpresswire • Dec 10, 2024
AliveCor's Kardia 12L ECG System Awarded Inc.'s 2024 Best in Business Awards
prnewswire • Dec 05, 2024
AliveCor's Services & Solutions are Now Available to Veterans
prnewswire • Nov 07, 2024
AliveCor launches point-of-care ECG tech in Europe
massdevice • Aug 03, 2024
AliveCor launches InstantQT in Europe for ECG evaluations
finance • Aug 03, 2024
Investors in AliveCor
Discover investors in AliveCor stock and explore their portfolio companies
AliveCor Management
Leadership team at AliveCor
CEO
Priya Abani
Co-Founder & Chief Medical Officer
David Albert
Join now and verify your accreditation status to gain access to:
- AliveCor current valuation
- AliveCor stock price
- Available deals in AliveCor and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading AliveCor Stock
How to invest in AliveCor stock?
Accredited investors can buy pre-IPO stock in companies like AliveCor through EquityZen funds. These investments are made available by existing AliveCor shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell AliveCor stock?
Shareholders can sell their AliveCor stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
